Tag

BMWS

Emerson Real-Time Modeling System in Takeda’s Los Angeles Plasma Fractionation Facility
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Emerson Real-Time Modeling System in Takeda’s Los Angeles Plasma Fractionation Facility

Expected benefits of integrated scheduling and modeling Building the model Integrating the model with various systems Switching to a new scheduling software in manufacturing — Sean Ganley AGILE Champion III Takeda Sean is part of the AGILE team at Takeda’s Los Angeles plasma manufacturing facility. AGILE, in all caps, is Takeda’s methodology for transforming its manufacturing capabilities. Following his bachelor’s degree in Biology from Occidental College, Sean began his 15-year tenure at Takeda. He has shaped the landscape of fractionation performance measurement and used his data and modeling methodologies to facilitate strategic growth of the site’s fractionation capacity by 120%….

Continue reading
Realizing Gilead’s 2030 Ambition: Advancing a Diverse Portfolio with a Complex Manufacturing Network
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Realizing Gilead’s 2030 Ambition: Advancing a Diverse Portfolio with a Complex Manufacturing Network

Gilead’s ambition is moving from a predominantly virology focused portfolio to a more diverse one with an emphasis on adding oncology and inflammation asset To accomplish this a wide net needed to be deployed to rapidly build a portfolio through external sourcing and internal innovation This has resulted in a diverse set of acquisitions, partnerships, opt-ins, and collaborations across program phases and modalities, resulting in a complex manufacturing network This talk will cover the strategies being deployed across the pillars of Process Development, Supply Chain, Quality, Regulatory, and External Manufacturing to realize Gilead’s 2030 ambition — Art Hewig VP of…

Continue reading
Establishing a ‘Culture of Data’ in Pharma Manufacturing
LIFE SCIENCES, VIDEO, LIFE SCIENCES

Establishing a ‘Culture of Data’ in Pharma Manufacturing

Pharmaceutical manufacturers have worked diligently and successfully to foster a ‘culture of quality’, resulting in fewer overall regulatory citations year over year since 2010. How can better data management and analytics impact not only quality but process improvement and efficiency gains as well? What trends are driving the need to move towards both managing and using data better? The ‘culture of data’ starts with changing old ways of working. What steps do biopharma manufacturers need to take to initiate their transformation? How can manufacturers use manufacturing process data to quickly and proactively improve outcomes? — Vishaka Rajaram Director, Pharmaceutical and…

Continue reading